Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Augello MA"'
Autor:
McNair, C, Urbanucci, A, Comstock, CES, Augello, MA, Goodwin, JF, Launchbury, R, Zhao, SG, Schiewer, MJ, Ertel, A, Karnes, J, Davicioni, E, Wang, L, Wang, Q, Mills, IG, Feng, FY, Li, W, Carroll, JS, Knudsen, KE
The androgen receptor (AR) is required for prostate cancer (PCa) survival and progression, and ablation of AR activity is the first line of therapeutic intervention for disseminated disease. While initially effective, recurrent tumors ultimately aris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c1fcf13647976625f9ba532af119717
Autor:
Augello MA, Chen X, Liu D, Lin K, Hakansson A, Sjöström M, Khani F, Deonarine LD, Liu Y, Travascio-Green J, Wu J, Loda M, Feng FY, Robinson BD, Davicioni E, Sboner A, Barbieri CE
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Feb 27. Date of Electronic Publication: 2024 Feb 27.
Autor:
Deshpande AS; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA.; Tri-Institutional PhD Program in Computational Biology and Medicine, New York, NY, USA., Ulahannan N; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA., Pendleton M; Oxford Nanopore Technologies, New York, NY, USA., Dai X; Oxford Nanopore Technologies, New York, NY, USA., Ly L; Oxford Nanopore Technologies, San Francisco, CA, USA., Behr JM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA.; Tri-Institutional PhD Program in Computational Biology and Medicine, New York, NY, USA., Schwenk S; Oxford Nanopore Technologies, Oxford, UK., Liao W; New York Genome Center, New York, NY, USA., Augello MA; Department of Urology, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Tyer C; Oxford Nanopore Technologies, New York, NY, USA., Rughani P; Oxford Nanopore Technologies, New York, NY, USA., Kudman S; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Tian H; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA., Otis HG; New York Genome Center, New York, NY, USA.; Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program, New York, NY, USA., Adney E; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; New York Genome Center, New York, NY, USA., Wilkes D; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Mosquera JM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Barbieri CE; Department of Urology, Weill Cornell Medicine, New York, NY, USA.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA., Melnick A; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.; Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA., Stoddart D; Oxford Nanopore Technologies, Oxford, UK., Turner DJ; Oxford Nanopore Technologies, New York, NY, USA.; Oxford Nanopore Technologies, San Francisco, CA, USA.; Oxford Nanopore Technologies, Oxford, UK., Juul S; Oxford Nanopore Technologies, New York, NY, USA.; Oxford Nanopore Technologies, San Francisco, CA, USA.; Oxford Nanopore Technologies, Oxford, UK., Harrington E; Oxford Nanopore Technologies, New York, NY, USA., Imieliński M; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. mski@mskilab.org.; New York Genome Center, New York, NY, USA. mski@mskilab.org.; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. mski@mskilab.org.; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA. mski@mskilab.org.; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA. mski@mskilab.org.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2022 Oct; Vol. 40 (10), pp. 1488-1499. Date of Electronic Publication: 2022 May 30.
Autor:
Cai PY; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Asad M; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Augello MA; Meyer Cancer Center, Weill Cornell Medicine, New York, NY., Martin L; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY., Louie C; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Basourakos SP; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Gaffney CD; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Shoag J; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH., Tu JJ; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Khani F; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY., Mosquera JM; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY., Loda M; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, New York, NY., Scherr DS; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY., Barbieri CE; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, New York, NY. Electronic address: chb9074@med.cornell.edu., Robinson BD; Department of Urology, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, New York, NY; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY. Electronic address: brr2006@med.cornell.edu.
Publikováno v:
Urologic oncology [Urol Oncol] 2022 Jun; Vol. 40 (6), pp. 271.e1-271.e7. Date of Electronic Publication: 2022 Apr 28.
Autor:
Grbesa I; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA., Augello MA; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA., Liu D; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA., McNally DR; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY 10065, USA; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Department of Medicine and Weill Cornell Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA., Gaffney CD; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA., Huang D; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA., Lin K; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA., Ivenitsky D; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA., Goueli R; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA., Robinson BD; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Khani F; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Deonarine LD; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA., Blattner M; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Elemento O; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Davicioni E; GenomeDx Bioscience, Vancouver, BC V6B 4X2, Canada., Sboner A; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10065, USA; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY 10065, USA., Barbieri CE; Department of Urology, Weill Cornell Medicine, New York, NY 10065, USA; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10065, USA; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10065, USA. Electronic address: chb9074@med.cornell.edu.
Publikováno v:
Cell reports [Cell Rep] 2021 Sep 07; Vol. 36 (10), pp. 109625.
Autor:
Liu D; Sandra and Edward Meyer Cancer Center and.; Department of Urology, Weill Cornell Medicine, New York, New York, USA.; HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York, USA.; Englander Institute for Precision Medicine of Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, New York, USA., Augello MA; Sandra and Edward Meyer Cancer Center and.; Department of Urology, Weill Cornell Medicine, New York, New York, USA., Grbesa I; Sandra and Edward Meyer Cancer Center and.; Department of Urology, Weill Cornell Medicine, New York, New York, USA., Prandi D; Fondazione Bruno Kessler (FBK), Trento, Italy., Liu Y; GenomeDx Bioscience Inc, Vancouver, British Columbia, Canada., Shoag JE; Department of Urology, Weill Cornell Medicine, New York, New York, USA.; University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.; Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, Minnesota, USA., Trock BJ; Department of Urology, Johns Hopkins University, Baltimore, Maryland, USA., Klein EA; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA., Den RB; Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Demichelis F; Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy., Davicioni E; GenomeDx Bioscience Inc, Vancouver, British Columbia, Canada., Sboner A; Sandra and Edward Meyer Cancer Center and.; HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medical College, New York, New York, USA.; Englander Institute for Precision Medicine of Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, New York, USA.; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA., Barbieri CE; Sandra and Edward Meyer Cancer Center and.; Department of Urology, Weill Cornell Medicine, New York, New York, USA.; Englander Institute for Precision Medicine of Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, New York, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2021 May 17; Vol. 131 (10).
Autor:
Berger A; Department of Pathology and Laboratory Medicine., Brady NJ; Department of Pathology and Laboratory Medicine., Bareja R; Caryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital., Robinson B; Department of Pathology and Laboratory Medicine.; Caryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital., Conteduca V; Department of Medicine., Augello MA; Department of Urology, and., Puca L; Department of Medicine., Ahmed A; Department of Biochemistry, Weill Cornell Medicine, New York, New York, USA., Dardenne E; Department of Pathology and Laboratory Medicine., Lu X; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Hwang I; Department of Pathology and Laboratory Medicine., Bagadion AM; Department of Pathology and Laboratory Medicine., Sboner A; Department of Pathology and Laboratory Medicine.; Caryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.; Department of Physiology and Biophysics, Institute for Computational Biomedicine, and.; Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA., Elemento O; Caryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.; Department of Physiology and Biophysics, Institute for Computational Biomedicine, and.; Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA., Paik J; Department of Pathology and Laboratory Medicine.; Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA., Yu J; Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Barbieri CE; Caryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.; Department of Urology, and.; Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA., Dephoure N; Department of Biochemistry, Weill Cornell Medicine, New York, New York, USA.; Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA., Beltran H; Caryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.; Department of Medicine.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Rickman DS; Department of Pathology and Laboratory Medicine.; Caryl and Israel Englander Institute for Precision Medicine, NewYork-Presbyterian Hospital.; Meyer Cancer Center, Weill Cornell Medicine, New York, New York, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2019 Jul 01; Vol. 129 (9), pp. 3924-3940. Date of Electronic Publication: 2019 Jul 01.
Autor:
Augello MA, Liu D, Deonarine LD, Robinson BD, Huang D, Stelloo S, Blattner M, Doane AS, Wong EWP, Chen Y, Rubin MA, Beltran H, Elemento O, Bergman AM, Zwart W, Sboner A, Dephoure N, Barbieri CE
Publikováno v:
Cancer cell [Cancer Cell] 2019 May 13; Vol. 35 (5), pp. 817-819.
Autor:
de Leeuw R; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., McNair C; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Schiewer MJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Neupane NP; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Brand LJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Augello MA; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania., Li Z; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey., Cheng LC; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.; Graduate Program in Cellular and Molecular Pharmacology, School of Graduate Studies, Rutgers, The State University of New Jersey, Piscataway, New Jersey.; Graduate Program in Quantitative Biomedicine, School of Graduate Studies, Rutgers, The State University of New Jersey, Piscataway, New Jersey., Yoshida A; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Courtney SM; Center for Genomic Medicine Bioinformatics, Medical University of South Carolina (MUSC), Charleston, South Carolina.; Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina., Hazard ES; Center for Genomic Medicine Bioinformatics, Medical University of South Carolina (MUSC), Charleston, South Carolina.; Library Science and Informatics, Medical University of South Carolina, Charleston, South Carolina., Hardiman G; Center for Genomic Medicine Bioinformatics, Medical University of South Carolina (MUSC), Charleston, South Carolina.; Departments of Medicine and Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina., Hussain MH; Division of Hematology and Oncology, Department of Medicine, Feinberg School of Medicine, Robert H. Lurie Cancer Center, Northwestern University, Chicago, Illinois., Diehl JA; Department of Biochemistry and Molecular Biology, Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina., Drake JM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.; Graduate Program in Cellular and Molecular Pharmacology, School of Graduate Studies, Rutgers, The State University of New Jersey, Piscataway, New Jersey.; Graduate Program in Quantitative Biomedicine, School of Graduate Studies, Rutgers, The State University of New Jersey, Piscataway, New Jersey.; Division of Medical Oncology, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey., Kelly WK; Department of Medical Oncology, Urology and Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania., Knudsen KE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. karen.knudsen@jefferson.edu.; Department of Medical Oncology, Urology and Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.; Sidney Kimmel Cancer Center, Thomas Jefferon University, Philadelphia, Pennsylvania.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Sep 01; Vol. 24 (17), pp. 4201-4214. Date of Electronic Publication: 2018 May 08.
Autor:
McNair C; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Urbanucci A; Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospitals, Oslo, Norway.; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospitals, Oslo, Norway., Comstock CE; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Augello MA; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Goodwin JF; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Launchbury R; Cambridge Research Institute, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Zhao SG; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Schiewer MJ; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Ertel A; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Karnes J; Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, MN, USA., Davicioni E; GenomeDx Biosciences, San Diego, CA, USA., Wang L; Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, MN, USA., Wang Q; Ohio State University College of Medicine, Columbus, OH, USA., Mills IG; Prostate Cancer Research Group, Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospitals, Oslo, Norway.; Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospitals, Oslo, Norway.; Prostate Cancer UK/Movember Centre of Excellence for Prostate Cancer Research, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK., Feng FY; Department of Radiation Oncology, Urology, and Medicine and Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA., Li W; Dan L. Duncan Cancer Center and Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, USA., Carroll JS; Cambridge Research Institute, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Knudsen KE; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Publikováno v:
Oncogene [Oncogene] 2017 Mar 23; Vol. 36 (12), pp. 1655-1668. Date of Electronic Publication: 2016 Sep 26.